March 12, 2020 / 4:14 PM / 19 days ago

BRIEF-Tenax Therapeutics Completes Enrollment In Phase 2 Pulmonary Hypertension Trial

March 12 (Reuters) - Tenax Therapeutics Inc:

* TENAX THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2 PULMONARY HYPERTENSION TRIAL

* TENAX THERAPEUTICS - TOP-LINE DATA FOR PHASE 2 PULMONARY HYPERTENSION TRIAL EXPECTED IN Q2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below